Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
17-AAG
HSP90
HSP90
9254.037
uM
0.19480
0.66652
-0.5117 -0.5396 0.5950 0.5855
0.9698
0.8345
HCC1395
TNBC
Basal B
17-AAG
HSP90
HSP90
7814.04
uM
0.08640
0.24294
-0.6919 -0.5378 0.7063 0.7010
0.9709
0.8711
HCC1395
TNBC
Basal B
17-AAG
HSP90
HSP90
9258.037
uM
0.09754
0.36203
-0.8344 -0.7213 0.6809 0.7182
0.9730
0.6992
HCC1395
TNBC
Basal B
17-AAG
HSP90
HSP90
7816.05
uM
0.16073
0.17234
-0.2105 -0.0721 1.9302 0.5052
0.9819
1.0200
HCC1395
TNBC
Basal B
5-DFUR
TYMS
TYMS
12000.143
uM
84.36160
1000.00000
-0.3079 -0.7342 0.3654 0.3948
0.8405
0.8939
HCC1395
TNBC
Basal B
5-DFUR
TYMS
TYMS
12084.143
uM
289.26680
1000.00000
-0.1951 -0.5512 0.5991 0.3095
0.9146
1.3499
HCC1395
TNBC
Basal B
5-FU
TYMS
TYMS
7813.017
uM
796.13610
1000.00000
-0.3296 -0.2150 1.5689 0.2351
0.9750
0.8685
HCC1395
TNBC
Basal B
5-FU
TYMS
TYMS
7816.017
uM
5569.35590
1000.00000
0.3951 0.3058 0.5506 0.1699
0.9805
1.2318
HCC1395
TNBC
Basal B
5-FU
TYMS
TYMS
9258.03
uM
607.47860
1000.00000
-0.8573 -0.7154 1.7821 0.3361
0.9845
0.4015
HCC1395
TNBC
Basal B
5-FU
TYMS
TYMS
7814.017
uM
306.00360
1000.00000
-0.5095 -0.6608 0.7113 0.3922
0.9860
0.8254
HCC1395
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
12000.165
uM
1.06870
2.54330
-0.9983 -1.0000 1.2671 0.5583
0.9902
0.6978
HCC1395
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
12084.158
uM
1.49040
3.26980
-0.9851 -1.0000 1.3984 0.4850
0.9943
1.2976
HCC1395
TNBC
Basal B
AG1024
IGF1R
RTK
7435.066
uM
inf
inf
0.8858 0.8858 0.0000 0.0656
-0.0232
0.8924
HCC1395
TNBC
Basal B
AG1024
IGF1R
RTK
7436.066
uM
inf
4.570
0.5866 0.5741 1.8013 0.0928
0.8508
1.2738
HCC1395
TNBC
Basal B
AG1478
EGFR
ErbB
7813.016
uM
inf
inf
0.8734 0.8734 0.0000 0.0271
0.1722
0.8531
HCC1395
TNBC
Basal B
AG1478
EGFR
ErbB
7816.016
uM
inf
inf
0.4398 0.4398 0.0000 0.1476
0.3491
1.1183
HCC1395
TNBC
Basal B
AG1478
EGFR
ErbB
7815.016
uM
inf
inf
0.2498 0.2498 0.0000 0.0580
0.3971
0.4370
HCC1395
TNBC
Basal B
AG1478
EGFR
ErbB
7814.016
uM
22.10670
46.38880
-0.7749 -1.0000 1.4822 0.2711
0.9828
0.8623
HCC1395
TNBC
Basal B
AS-252424
PI3K
PI3K
12084.158
uM
65.63810
363.1330
0.4863 -1.0000 0.6422 0.0778
0.8932
1.2976
HCC1395
TNBC
Basal B
AS-252424
PI3K
PI3K
12000.165
uM
105.32320
9.98050
0.5381 0.4952 1.9724 0.0455
0.8937
0.6978
HCC1395
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7436.073
uM
11.77990
9.54750
0.2809 0.2806 3.9209 0.1875
0.9718
1.2318
HCC1395
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7435.073
uM
20.17280
25.02740
-0.1776 -0.2231 1.7109 0.1764
0.9828
0.7153
HCC1395
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7435.074
uM
0.02593
0.04552
-0.8969 -0.9050 1.8359 1.2360
0.9935
0.8579
HCC1395
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7435.074
uM
0.02593
0.04552
-0.8969 -0.9050 1.8359 1.2360
0.9935
0.8579
HCC1395
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7436.074
uM
0.04608
0.07970
-0.8305 -0.8281 1.7831 1.1039
0.9977
1.2173